Abeona Therapeutics(ABEO) - 2025 Q4 - Annual Report
Abeona TherapeuticsAbeona Therapeutics(US:ABEO)2026-03-17 11:36
Transcript

For the fiscal year ended December 31, 2025 Or UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission file number 001-15771 ABEONA THERAPEUTICS INC. (Exact name of registrant as specified in its charter) (State or Other Jurisdiction of i ...